AEQUITA PHARMACY: 13 recalls on record

Recalls filed with 1 agency: FDA (13).

First recall on record: August 13, 2025. Most recent: August 13, 2025.

Risk classification: Class II: 13

Most recent recalls

DateAgencyProduct
August 13, 2025FDATirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syri…D-0557-2025
August 13, 2025FDATirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syrin…D-0555-2025
August 13, 2025FDATirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syri…D-0556-2025
August 13, 2025FDASemaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject …D-0564-2025
August 13, 2025FDATirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syri…D-0559-2025
August 13, 2025FDASemaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on …D-0553-2025
August 13, 2025FDASemaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on …D-0562-2025
August 13, 2025FDATirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on sy…D-0558-2025
August 13, 2025FDASemaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on …D-0565-2025
August 13, 2025FDATirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syrin…D-0554-2025
August 13, 2025FDASemaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on sy…D-0563-2025
August 13, 2025FDATirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syr…D-0560-2025
August 13, 2025FDASemaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on…D-0561-2025

Questions about this company

How many recalls does AEQUITA PHARMACY have?
Recalert has 13 U.S. recalls on record for AEQUITA PHARMACY, published between August 13, 2025 and August 13, 2025.
What was the most recent AEQUITA PHARMACY recall?
FDA recall D-0557-2025, published August 13, 2025: Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland…
Which agencies have handled AEQUITA PHARMACY recalls?
AEQUITA PHARMACY appears as the recalling firm in recalls from: FDA (13).

Do you carry products from AEQUITA PHARMACY? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies